Pnc Financial Services Group, Inc. Biomarin Pharmaceutical Inc Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 12,090 shares of BMRN stock, worth $805,556. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,090
Previous 8,968
34.81%
Holding current value
$805,556
Previous $738,000
15.04%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding BMRN
# of Institutions
637Shares Held
177MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.52 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.28 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.26 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$926 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$699 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.4B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...